Who Paid My Doc
Evgueni Fayn
Clinical Cardiac Electrophysiology Milwaukee, WI Medical Doctor
NPI 1336181072 CMS profile 241651
9200 W Wisconsin Ave, Division Of Cardiovascular Disease, Milwaukee, WI 53226
General payments
$4,335
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Evgueni Fayn of Milwaukee, WI is reported in the CMS Open Payments database as having received $4,335 across 33 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 19th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,051 | 7 | |
| 2024 | General | $2,623 | 18 | |
| 2022 | General | $578 | 6 | |
| 2021 | General | $84 | 2 |
Beside peers
- Evgueni Fayn
- Clinical Cardiac Electrophysiology median
- Middle half of Clinical Cardiac Electrophysiology
- National median
In program year 2025, general payments to Evgueni Fayn were reported at $1,051. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.
Show as a table
| Year | Evgueni Fayn | Clinical Cardiac Electrophysiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $2,361 | $585–$8,260 | $163 |
| 2020 | $0 | $993 | $247–$4,351 | $114 |
| 2021 | $84 | $1,185 | $326–$4,739 | $132 |
| 2022 | $578 | $2,073 | $554–$6,789 | $149 |
| 2023 | $0 | $2,568 | $759–$8,159 | $160 |
| 2024 | $2,623 | $2,557 | $703–$7,403 | $164 |
| 2025 | $1,051 | $2,462 | $733–$7,710 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
901
Drug cost
$233,446
Branded share of claims
29.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 170 | $195,073 | |
| Dofetilide | Generic | 78 | $14,189 | |
| Xarelto Rivaroxaban | Brand | 16 | $11,545 | |
| Flecainide Acetate | Generic | 121 | $4,858 | |
| Metoprolol Succinate | Generic | 210 | $3,292 | |
| Sotalol Sotalol Hcl | Brand | 62 | $1,663 | |
| Amiodarone Hcl | Generic | 110 | $1,364 | |
| Carvedilol | Generic | 38 | $376 | |
| Bisoprolol Fumarate | Generic | 15 | $362 | |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | Brand | 14 | $354 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 51 billing codesPaid by Medicare
$37,630
Medicare patients
427
Services billed
960
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Atrial fibrillation | 58% | |
| Heart failure | 49% | |
| Arthritis | 49% | |
| Ischemic heart disease | 48% | |
| Chronic kidney disease | 42% | |
| Diabetes | 35% | |
| Depression | 28% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
33 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Cardiac Electrophysiology in Wisconsin
Imran Niazi
Clinical Cardiac Electrophysiology · Milwaukee, WI
Miguel Leal
Clinical Cardiac Electrophysiology · Madison, WI
Jodi Zilinski
Clinical Cardiac Electrophysiology · Milwaukee, WI
Sanjay Deshpande
Clinical Cardiac Electrophysiology · Beloit, WI
Divya Korpu
Clinical Cardiac Electrophysiology · Eau Claire, WI
Marcie Berger
Clinical Cardiac Electrophysiology · Milwaukee, WI
Related records
Clinical Cardiac Electrophysiology in Wisconsin
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Cardiac Electrophysiology
Everyone recorded under this specialty, nationwide.
Doctors in Wisconsin
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.